SLNO

Soleno Therapeutics, Inc.

44.78 USD
-1.38 (-2.99%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Soleno Therapeutics, Inc. stock is up 19.41% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 70% of the previous 9 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Apr 19:04 21 Jun, 2024 45.00 CALL 100 1007
29 Apr 13:35 17 May, 2024 50.00 CALL 298 1
29 Apr 13:43 17 May, 2024 50.00 PUT 100 0
29 Apr 14:01 21 Jun, 2024 55.00 CALL 109 459
29 Apr 14:02 21 Jun, 2024 55.00 CALL 134 459
29 Apr 14:09 21 Jun, 2024 55.00 CALL 147 459
29 Apr 14:11 21 Jun, 2024 55.00 CALL 250 459
29 Apr 14:16 21 Jun, 2024 55.00 CALL 164 459
29 Apr 14:20 17 May, 2024 50.00 PUT 100 0
06 May 14:56 21 Jun, 2024 55.00 CALL 196 1223

About Soleno Therapeutics, Inc.

Soleno Therapeutics is a clinical-stage biopharmaceutical company. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name in May 2017.

  • Oppenheimer
    Mon May 13, 08:35
    buy
    confirm
  • Baird
    Fri May 10, 05:17
    buy
    initial